About the Author

James C. Capretta

James C. Capretta

New Atlantis Contributing Editor James C. Capretta is an expert on health care and entitlement policy, with years of experience in both the executive and legislative branches of government. E-mail: jcapretta@aei.org.


 READ MORE

James C. Capretta’s Latest New Atlantis Articles

 Health Care with a Conscience” (Fall 2008) 

 Health Care 2008: A Political Primer” (Spring 2008) 

 The Clipboard of the Future” (Winter 2008)

 

 More on James C. Capretta

Text Patterns - by Alan JacobsFuturisms - Critiquing the project to reengineer humanity

Wednesday, February 11, 2009

What’s Wrong with “Comparative Effectiveness Research”? 

[Cross-posted at the Corner]

Let’s set aside the issue of whether funding for a new “comparative effectiveness research” (CER) program belongs in a “stimulus” billLet’s instead ask: Is CER a good idea on the merits?
 
In theory, CER is intended to ensure that medical decisions are grounded, whenever possible, in empirical evidence. The government would pay researchers to collect data and conduct experiments to determine what medical procedures actually improve patient health. That seems reasonable enough: Too often, patients receive care for which there is little evidence demonstrating effectiveness. 
 
But CER is only going to be beneficial to our health if the research is well-executed and put to good use. This raises a new question: Who is calling the shots, cost-conscious consumers or the government? 
 
In the hands of consumers, new evidence on efficacy, especially if comes from many sources, can be weighed against other concerns. That’s crucial, because as Scott Gottlieb demonstrates i
n this excellent piece, evidence from CER will rarely be definitive enough to mandate specific judgments on treatment options. 
 
By contrast, government bureaucracies don’t do nuance and subtlety very well. If the federal government is in charge, the tendency will be to take single studies and use them to make decisions for the entire population. 
 
That’s why Betsy McCaughey was right to say in
this piece that the CER funding in the “stimulus” legislation is really the first installment of Obamacare. The president and his allies in Congress believe that the federal government is up to the task of managing the health sector. 
 
But evidence from around the world indicates that centralized government control always leads to price controls, under-funding of institutional care, arbitrary restrictions on access to new drugs and technology, and a drying up of investment in medical innovation. That’s certainly not “stimulus,” or the kind of health-care “change” the public wants.

posted by James C. Capretta | 4:07 pm
File As: Health Care